Roche scoops up a Treg player for the I/O team, plucking 1 drug and spinning off a 2nd into a new biotech
Roche has snapped up a British biotech which has its own special twist on immuno-oncology — and a couple of key Yank associates in high-profile roles …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
